A conference focused on advancing engineered vision technologies.
Engineered Vision Conference (EVC)
['FUNDING_OTHER'] · UNIVERSITY OF SOUTHERN CALIFORNIA · NIH-11002904
The Engineered Vision Conference is a friendly gathering where top experts come together to share ideas and solutions about new technologies that could help improve vision, focusing on things like electronic devices, cell treatments, and gene therapies.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF SOUTHERN CALIFORNIA (nih funded) |
| Locations | 1 site (Los Angeles, UNITED STATES) |
| Trial ID | NIH-11002904 on ClinicalTrials.gov |
What this research studies
The Engineered Vision Conference (EVC) aims to bring together leading experts in vision research, cell and gene therapy, and biomedical engineering to discuss advancements in engineered vision technologies. The conference will focus on three main areas: bioelectronic devices, cell-based therapies, and gene therapies, addressing common engineering challenges and clinical endpoints. Participants will collaborate to identify obstacles in these fields and develop strategic plans to overcome them, fostering innovation and potential breakthroughs in vision restoration and enhancement.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by vision loss or blindness who are interested in emerging therapies.
Not a fit: Patients with stable vision or those not affected by vision-related conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in treatments for vision impairment and blindness.
How similar studies have performed: Previous conferences and collaborations in related fields have successfully advanced technologies and therapies, indicating a promising potential for this initiative.
Where this research is happening
Los Angeles, UNITED STATES
- UNIVERSITY OF SOUTHERN CALIFORNIA — Los Angeles, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HUMAYUN, MARK S — UNIVERSITY OF SOUTHERN CALIFORNIA
- Study coordinator: HUMAYUN, MARK S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.